ArticleVaccine2022

Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.

Natalia Abraham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.